Veradigm | MDRX - Ebitda

Stock Price
4.31
Daily Change
-0.19 -4.22%
Monthly
-6.30%
Yearly
-15.49%
Q1 Forecast
7.75

Veradigm reported $38.81M in EBITDA for its fiscal quarter ending in September of 2022.





Ebitda Change Date
Alcidion AUD 4.56M 4.23M Jun/2025
Ambu A/S DKK 261M 17M Dec/2025
Amplifon EUR 107.33M 38.85M Sep/2025
Cardinal Health USD 981M 5M Dec/2025
Centene USD -903M 1.02B Dec/2025
Charles River Laboratories USD 258.06M 24.83M Dec/2025
Cigna USD 2.86B 56M Mar/2025
Convatec Group USD 286.8M 27.5M Dec/2024
CVS Health USD 3.74B 349M Dec/2025
Diasorin EUR 87M 10M Sep/2025
Elevance Health USD 2.19B 1.01B Sep/2025
General Electric Aerospace USD 3.04B 185M Sep/2025
Gulf Medical Proj AED 35.5M 2.9M Mar/2025
Humana USD -290M 1.11B Dec/2025
IQVIA Holdings USD 1.05B 97M Dec/2025
Laboratory Of America USD 588.1M 24.1M Dec/2025
Maximus USD 170.41M 10.34M Dec/2025
McKesson USD 1.68B 418M Sep/2025
Med Life RON 78.06M 38.06M Jun/2025
Molina Healthcare USD 185M 265M Sep/2025
Omnicell USD 41.13M 2.76M Sep/2025
Oriola-kd EUR 9.6M 1.5M Sep/2025
Owens Minor USD 96.6M 12.17M Jun/2025
Quest Diagnostics USD 537M 24M Dec/2025
Rede D'or Sao Luiz BRL 3.27B 528.14M Sep/2025
Siemens Healthineers EUR 1.11B 83M Dec/2025
Supermax Corporation Bhd MYR -141.38M 42.01M Sep/2025
UnitedHealth USD 1.5B 3.92B Dec/2025
Veeva Systems USD 370.83M 12.2M Sep/2025
Veradigm USD 38.81M 29.61M Sep/2022
Xerox USD 110M 54M Jun/2025